May 3, 2024
RegMed Investors (RMi) Closing Bell: green on the sector screen, with a trickle starting to the downside
May 2, 2024
RegMed Investors (RMi) Closing Bell: a sigh of relief as sector adds value after earnings releases
May 1, 2024
RegMed Investors (RMi) Closing Bell: the path forward
April 30, 2024
RegMed Investors (RMi) Closing Bell: ending April on a sour note
April 29, 2024
RegMed Investors (RMi) Closing Bell: a month of up, downs; I thought were exercise
April 26, 2024
RegMed Investors (RMi) Closing Bell: I bowed the knee to thank the upside relief
April 25, 2024
RegMed Investors (RMi) Closing Bell: hammered
April 24, 2024
RegMed Investors (RMi) Closing Bell: I told you so
April 23, 2024
RegMed Investors (RMi) Closing Bell: welcoming the upside trend
April 22, 2024
RegMed Investors (RMi) Closing Bell: a flash sector relief rally?
April 19, 2024
RegMed Investors (RMi) Closing Bell: a tough week; tied to cross-currents of geopolitical conflicts and recurring inflation
April 17, 2024
RegMed Investors (RMi) Closing Bell: start thinking of sector equities’ future direction without the geopolitical cloud overhead
April 16, 2024
RegMed Investors (RMi) Closing Bell: declining threads extend
April 11, 2024
RegMed Investors (RMi) Closing Bell: sector seeps, although with subdued selling
April 10, 2024
RegMed Investors (RMi) Closing Bell: the cell and gene therapy sector got chewed-up, bloods everywhere
April 8, 2024
RegMed Investors (RMi) Closing Bell: what’s moving the sector?
April 5, 2024
RegMed Investors (RMi) Closing Bell: economic circumstances drove a 5 session/weekly downside
April 4, 2024
RegMed Investors (RMi) Closing Bell: economics undermine sector’s share pricing before jobs report
April 3, 2024
RegMed Investors (RMi) Closing Bell: The switch is still flipped
April 2, 2024
RegMed Investors (RMi) Closing Bell: weakness is more of a wipe-out
April 1, 2024
RegMed Investors (RMi) Closing Bell: An early share pricing eclipse in first session of April?
My motto … never leave an investor uninformed! I say today what others won’t, so you can do what others can’t.
My name is Henry McCusker; I endorse these opinions under my own name and with a subscription based membership.
Do you have an opinion you would like to share with us? We would like to hear from you.
Please e-mail us at hwm@regmedinvestors.com.
Editor and Publisher ... Henry McCusker enters his tenth (10th) year at RegMed Investors